By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Evotec today announced it has signed a definitive agreement to purchase Kinaxo Biotechnologies for up to €16 million ($22 million) in a cash and stock deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.